Related Experiment Video

Updated: Aug 1, 2025

Implantation of Total Artificial Heart in Congenital Heart Disease
07:27

Implantation of Total Artificial Heart in Congenital Heart Disease

Published on: July 18, 2014

24.7K

COVID-19 in Cyanotic Congenital Heart Disease

Lama A Ammar1, Joseph E Nassar1, Fadi Bitar1

  • 1Faculty of Medicine and Medical Center, American University of Beirut, Bliss Street, 11-0236, Riad El-Solh, Beirut 1107-2020, Lebanon.

The Canadian Journal of Infectious Diseases & Medical Microbiology = Journal Canadien Des Maladies Infectieuses Et De La Microbiologie Medicale
|April 28, 2023
PubMed

Insights

Patients with cyanotic congenital heart disease (CHD) face higher risks from COVID-19 infection. These individuals require critical care due to increased susceptibility to severe complications and mortality.

Area of Science:

  • Cardiology
  • Infectious Diseases
  • Pediatrics

Background:

  • Congenital heart disease (CHD) is the most common birth defect, presenting diverse symptoms and severities.
  • Classifying CHD into cyanotic and acyanotic types is crucial for understanding disease progression.
  • Patients with CHD possess underlying cardiac vulnerabilities that may be exacerbated by infections.

Purpose of the Study:

  • To investigate the clinical course and outcomes of Coronavirus disease 2019 (COVID-19) in patients with cyanotic CHD.
  • To identify risk factors and specific challenges associated with COVID-19 in this vulnerable population.
  • To emphasize the need for heightened medical vigilance in cyanotic CHD patients diagnosed with COVID-19.

Main Methods:

  • This is a review article, synthesizing existing literature on COVID-19 in cyanotic CHD patients.
  • The review analyzes the potential pathophysiological mechanisms linking COVID-19 and cyanotic CHD.
  • It examines reported clinical outcomes and complications in affected individuals.

Main Results:

  • Cyanotic CHD patients are at a higher risk of mortality and severe complications from COVID-19.
  • Physiological factors like cyanosis and pulmonary hypertension, rather than anatomical complexity, predict infection severity.
  • These patients experience continuous hypoxemia, increasing deterioration risk during respiratory infections and posing a higher risk for paradoxical embolism.

Conclusions:

  • COVID-19 poses a significant threat to patients with cyanotic CHD, potentially leading to worse outcomes than in acyanotic patients.
  • Management strategies must prioritize close monitoring, prompt medical intervention, and adequate supportive care for cyanotic CHD patients with COVID-19.
  • Understanding the heightened susceptibility and risks is essential for optimizing care and improving prognosis.

More Related Videos

Fetal Mouse Cardiovascular Imaging Using a High-frequency Ultrasound 30/45MHZ System07:34

Fetal Mouse Cardiovascular Imaging Using a High-frequency Ultrasound 30/45MHZ System

Published on: May 5, 2018

11.7K
Analysis of Congenital Heart Defects in Mouse Embryos Using Qualitative and Quantitative Histological Methods08:28

Analysis of Congenital Heart Defects in Mouse Embryos Using Qualitative and Quantitative Histological Methods

Published on: March 10, 2020

6.9K

Related Concept Videos

Cardiomyopathy III: Hypertrophic Cardiomyopathy01:29

Cardiomyopathy III: Hypertrophic Cardiomyopathy

Hypertrophic cardiomyopathy, or HCM, is an autosomal dominant genetic disorder characterized by asymmetric left ventricular hypertrophy without ventricular dilation. It is more common in men and is typically diagnosed in young, athletic adults.EtiologyHCM is primarily genetic and is caused by mutations in genes encoding sarcomeric proteins. Researchers have identified over 1400 mutations across at least 11 different genes. Among these, the most frequently occurring mutations are found in the...
18
Cardiomyopathy II: Dilated Cardiomyopathy01:30

Cardiomyopathy II: Dilated Cardiomyopathy

Dilated cardiomyopathy, or DCM, is a progressive myocardial disorder characterized by ventricular chamber dilation and contractile dysfunction.EtiologyVarious factors can cause DCM, including hypertension and heavy alcohol intake, which contribute to the weakening and enlargement of the heart muscle. Viral infections, such as Coxsackievirus B, adenoviruses, and influenza, can lead to DCM by causing inflammation and damage to heart tissue. Certain chemotherapeutic agents, including daunorubicin,...
13
Cardiomyopathy V: Interprofessional Care01:29

Cardiomyopathy V: Interprofessional Care

Managing cardiomyopathy involves addressing underlying or precipitating causes, treating heart failure with medications, and implementing dietary changes and a balanced exercise and rest regimen.Lifestyle ModificationsCardiomyopathy patients should adopt a low-sodium diet to reduce fluid retention and manage heart failure. A personalized exercise and rest plan helps maintain physical fitness without overstraining the heart. Avoiding alcohol and tobacco is essential to prevent further damage to...
20
Imbalances in Cardiac Output01:26

Imbalances in Cardiac Output

The heart's primary function is to pump blood throughout the body, maintaining a balance between blood sent out (cardiac output) and blood returning (venous return). If this balance is disrupted, it can result in congestive heart failure (CHF), a severe condition where the heart becomes an inefficient pump, leading to inadequate blood circulation.
CHF can occur due to the failure of either side of the heart. Left-side failure leads to pulmonary congestion—the right side continues to send...
1.4K
Mitral Stenosis I: Introduction01:22

Mitral Stenosis I: Introduction

Mitral Valve Stenosis (MVS) is a heart condition where the mitral valve narrows, impeding blood circulation from the left atrium to the left ventricle. The etiology and pathophysiology of this condition are multifaceted, leading to a cascade of cardiovascular complications.Causes of Mitral Valve StenosisRheumatic Heart Disease: It is the main cause of mitral valve stenosis, particularly in developing nations. This condition arises from rheumatic fever, an inflammatory illness resulting from...
20
Rheumatic Heart Disease I: Introduction01:23

Rheumatic Heart Disease I: Introduction

Rheumatic heart disease or RHD is a chronic condition that results from rheumatic fever, causing permanent damage to the heart valves.Etiology and Risk FactorsIt primarily arises from rheumatic fever, an inflammatory disease that can develop after untreated or inadequately treated group A streptococcal (GAS) pharyngitis. Streptococcus spreads through direct contact with oral or respiratory secretions. While the bacteria are the causative agents, factors like malnutrition, overcrowding, poor...
22